ETS1 Mediates MEK1/2-Dependent Overexpression of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Human Cancer Cells

• Anchit Khanna,

  Affiliations Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland, Tampere Graduate Program in Biomedicine and Biotechnology (TGPBB), University of Tampere, Tampere, Finland

  ⨯
• Juha Okkeri,

  Affiliation Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland

  ⨯
• Turker Bilgen,

  Affiliations Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland, Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland, Department of Medical Biology and Genetics, Faculty of Medicine, Akdeniz University, Antalya, Turkey

  ⨯
• Timo Tiirikka,

  Affiliation Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland

  ⨯
• Mauno Vihinen,

  Affiliation Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland

  ⨯
• Tapio Visakorpi,

  Affiliation Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland

  ⨯
• Jukka Westermarck

  * E-mail: jukwes@utu.fi

  Affiliations Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland, Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland, Department of Pathology, University of Turku, Turku, Finland

  ⨯